A 53-year-old man presents for evaluation of progressive shortness of breath. His symptoms are insidious in onset and he reports no cough, sputum, or chest discomfort. His past medical history is significant for well-controlled hypertension and type 2 diabetes. He is a lifetime nonsmoker and has no history of occupational exposure to inhaled organic or inorganic particles. Pulmonary function tests reveal a restrictive defect, and a high-resolution CT suggests pulmonary fibrosis. Which of the following is the most likely role of transbronchial biopsy in this condition?

**Core Concept**
Transbronchial biopsy is a diagnostic tool used to obtain tissue samples from the lungs, specifically from the airways, for histopathological examination. In the context of pulmonary fibrosis, the primary goal of transbronchial biopsy is to determine the underlying cause of the fibrotic process, which can be idiopathic or secondary to an underlying disease or condition.

**Why the Correct Answer is Right**
Transbronchial biopsy is particularly useful in cases of pulmonary fibrosis where the high-resolution CT scan and pulmonary function tests indicate a restrictive defect, but the underlying cause remains unclear. The biopsy sample can be examined for histopathological features of fibrosis, such as honeycombing, and can also be used to rule out other conditions that may mimic pulmonary fibrosis, such as lymphangitic carcinomatosis or sarcoidosis. The biopsy sample can also be sent for microbiological examination to rule out infectious causes of pulmonary fibrosis.

**Why Each Wrong Option is Incorrect**
**Option A:** Transbronchial biopsy is not typically used to assess the extent of pulmonary fibrosis, as it is a more invasive procedure and may not provide a complete picture of the disease process. Instead, imaging studies such as HRCT are more commonly used for this purpose.
**Option B:** Transbronchial biopsy is not typically used to diagnose pulmonary fibrosis, as the diagnosis is often made based on clinical presentation, imaging studies, and pulmonary function tests. However, the biopsy may be used to determine the underlying cause of the fibrotic process.
**Option C:** Transbronchial biopsy is not typically used to assess the response to treatment in pulmonary fibrosis, as the disease process is often complex and multifactorial. Instead, clinical response and imaging studies are more commonly used to assess treatment efficacy.

**Clinical Pearl / High-Yield Fact**
In cases of pulmonary fibrosis, it is essential to consider the possibility of underlying conditions that may mimic the disease process, such as lymphangitic carcinomatosis or sarcoidosis. A high index of suspicion and a thorough diagnostic workup, including transbronchial biopsy, are critical in making an accurate diagnosis and determining the underlying cause of the fibrotic process.

**Correct Answer: C.**

✓ Correct Answer: C. diagnose specific causes of interstitial lung disease